09:48 AM EST - Valeant Pharmaceuticals International, Inc. : announced today that it has entered into a settlement agreement with Anacor Pharmaceuticals to resolve all outstanding disputes between them, including the previously disclosed disputes involving Anacor and Valeant's subsidiaries, Dow Pharmaceutical Sciences, Inc. (Dow) and Medicis Pharmaceutical Corporation. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $0.40 at $118.00.
